“it might be challenging to prove apples-to-appl
Post# of 148188
(Total Views: 659)
Posted On: 07/23/2020 12:00:31 AM
“it might be challenging to prove apples-to-apples superiority over remdesivir which cut recovery time for patients hospitalized with COVID-19 by 4 days.“
Careful, you’re giving Remdesevir much more credit then it is due. The drug reduced hospitalization in only hospitalized patients who were on supplemental oxygen. Not those on high flow oxygen, ventilator, etc.
They cherry picked that endpoint.
Careful, you’re giving Remdesevir much more credit then it is due. The drug reduced hospitalization in only hospitalized patients who were on supplemental oxygen. Not those on high flow oxygen, ventilator, etc.
They cherry picked that endpoint.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼